Pakistan’s Highnoon Laboratories listed in Forbes Asia’s “200 Best Under a Billion”

Share on facebook
Share on twitter
Share on linkedin
Share on pinterest
Share on telegram
Share on whatsapp
Share on email
Share on print

Pakistan’s famed public limited company ‘Highnoon Laboratories’ got listed under Forbes Asia’s list of ‘200 Best Under a Billion companies. This list by Forbes includes 200 of the best-performing listed companies in the Asia-Pacific region. These companies are shortlisted from a total of 24,000 companies, making this listing even more prestigious for Highnoon and Pakistan.

This is the third time that Highnoon has been included in the Forbes list of the 200 best-performing listed companies. When making this list, Forbes measures these companies on metrics such as sales, profit growth, low debt levels, and governance.

A large variety of companies belonging to different countries and industries were included in the list, Pakistan held two spots in the list, one of which was for Highnoon, the other one for Systems Limited.

Speaking on his company’s success, Chairman Tausif Khan said that “We are delighted to stand among the success stories of the Asia Pacific region for the third time. We dedicate this accomplishment to the individuals of our company who do their best to be the best. We remain thankful to the health care professionals for their confidence, and we value our business partners for the enabling. We will continue to focus on providing products that enrich life by improving clinical outcomes.”

What is Highnoon?

A renowned pharma company, Highnoon serves as a healthcare partner for millions of Pakistani citizens. Known for its quality, Highnoon produces a wide variety of medicinal products that are used both locally and exported to other countries.

Despite being a growing pharmaceutical company, Highnoon is the only one in its industry to have received such recognition from big names like Forbes.